About
BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. The fund relies on the expertise of the Society’s medical and science professionals to evaluate the mission value of its investments. The fund’s goal is to accelerate delivery of promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.
Position in the VCSift Database
- • 33,888 investors in VCSift focus on the fintech sector.
- • 982 investors are based in Atlanta, Georgia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Stages
- series-a
- Sectors
- fintech
- Location
- Atlanta, US
Contact Information
Find more investors like BrightEdge
Search Investors